Lamotrigin Quadro Desitin

Lamotrigine, the active ingredient in Lamotrigin Quadro Desitin, is an anticonvulsant presented as an oral dosage form for oral use. It is employed in the management of certain seizure types and as maintenance therapy for bipolar disorder. GNH USA supplies Lamotrigin Quadro Desitin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine acts on neuronal excitability and is indicated for the following conditions: - Epilepsy (partial seizures): reduces the frequency and severity of seizure episodes. - Bipolar disorder (maintenance therapy): helps prevent mood episode recurrence and stabilises mood over the long term.

Lamotrigine may cause a range of adverse reactions. The profile includes both frequent, mild events and rare, serious conditions.

Common Side Effects: - Dizziness - Headache - Nausea - Rash (mild) - Insomnia - Blurred vision

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe skin reactions (e.g., bullous eruptions) - Blood dyscrasias (e.g., agranulocytosis) - Hepatic failure - Anaphylactic reactions - Severe hypersensitivity reactions

When prescribing or dispensing lamotrigine, several safety considerations are important. - Dose titration: increase gradually as prescribed to minimise rash risk. - Monitor skin: watch for any rash, especially during the first weeks of therapy. - Avoid abrupt discontinuation: sudden stop may increase seizure frequency. - Pregnancy: discuss potential risks with a healthcare professional before use. - Renal/hepatic impairment: dose may require adjustment based on organ function. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Lamotrigine interacts with several medicines; some require avoidance while others need close monitoring.

Major Interactions (Avoid): - Valproic acid: can raise lamotrigine plasma levels, increasing toxicity risk. - Carbamazepine: may lower lamotrigine levels, reducing efficacy. - Oral contraceptives: can enhance lamotrigine clearance, potentially requiring dose adjustment.

Moderate Interactions (Monitor Closely): - Phenobarbital or phenytoin: may decrease lamotrigine concentrations. - Serotonergic agents: monitor for signs of serotonin syndrome.